- Latest available (Revised)
- Point in Time (31/01/2020)
- Original (As adopted by EU)
Commission Regulation (EU) No 985/2013Show full title
Commission Regulation (EU) No 985/2013 of 14 October 2013 amending and correcting Annex I to Regulation (EC) No 1334/2008 of the European Parliament and of the Council as regards certain flavouring substances (Text with EEA relevance)
You are here:
- Regulations originating from the EU
- 2013 No. 985
- Annexes only
What Version
Advanced Features
- Show Geographical Extent(e.g. England, Wales, Scotland and Northern Ireland)
- Show Timeline of Changes
More Resources
Legislation originating from the EU
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
This item of legislation originated from the EU
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
Changes over time for: Commission Regulation (EU) No 985/2013 (Annexes only)
Alternative versions:
Status:
Point in time view as at 31/01/2020.
Changes to legislation:
There are currently no known outstanding effects for the Commission Regulation (EU) No 985/2013.
Changes to Legislation
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
ANNEXU.K.
Part A of Annex I to Regulation (EC) No 1334/2008 is amended as follows:
(1)
the entry concerning FL No 02.093 is replaced by the following:
| ‘02.093 | (Z)-Non-6-en-1-ol | 35854-86-5 | 324 | 10294 | JECFA’ |
(2)
the entry concerning FL No 02.110 is replaced by the following:
| ‘02.110 | 2,6-Dimethylhept-6-en-1-ol | 36806-46-9 | 348 | At least 90 %; secondary component 5-10 % 2,6-dimethyl-5-hepten-1-ol | JECFA’ |
(3)
the entry concerning FL No 02.145 is replaced by the following:
| ‘02.145 | 2,6-Dimethylocta-1,5,7-trien-3-ol | 29414-56-0 | EFSA’ |
(4)
the entry concerning FL No 02.194 is replaced by the following:
| ‘02.194 | Octa-1,5-dien-3-ol | 83861-74-9 | EFSA’ |
(5)
the entry concerning FL No 02.211 is replaced by the following:
| ‘02.211 | Undeca-1,5-dien-3-ol | 56722-23-7 | EFSA’ |
(6)
the entry concerning FL No 02.229 is replaced by the following:
| ‘02.229 | (-)-3,7-Dimethyl-6-octen-1-ol | 7540-51-4 | At least 90 % cis-isomer; secondary components 2-6 % di-unsaturated and saturated C10 alcohols, 2-4 % citronellyl acetate and 2-3 % citronellal | EFSA’ |
(7)
the entry concerning FL No 02.252 is replaced by the following:
| ‘02.252 | 4,8-Dimethyl-3,7-nonadien-2-ol | 67845-50-5 | 1841 | EFSA’ |
(8)
the entry concerning FL No 05.026 is replaced by the following:
| ‘05.026 | o-Tolualdehyde | 529-20-4 | EFSA’ |
(9)
the entry concerning FL No 05.028 is replaced by the following:
| ‘05.028 | m-Tolualdehyde | 620-23-5 | EFSA’ |
(10)
the entry concerning FL No 05.029 is replaced by the following:
| ‘05.029 | p-Tolualdehyde | 104-87-0 | EFSA’ |
(11)
the entry concerning FL No 05.085 is replaced by the following:
| ‘05.085 | (Z)-Hept-4-enal | 6728-31-0 | 320 | 2124 | At least 93 % of Z-form of hept-4-enal; secondary component 2-5 % of E-form of hept-4-enal. | JECFA’ |
(12)
the entry concerning FL No 05.137 is replaced by the following:
| ‘05.137 | Dec-4(cis)-enal | 21662-09-9 | At least 90 %; secondary component at least 5 % trans-isomer | EFSA’ |
(13)
the entry concerning FL No 05.182 is replaced by the following:
| ‘05.182 | 2,6,6-Trimethylcyclohex-2-ene-1-carboxaldehyde | 432-24-6 | EFSA’ |
(14)
the entry concerning FL No 07.190 is replaced by the following:
| ‘07.190 | Octa-1,5-dien-3-one | 65213-86-7 | 1848 | Mixture of stereoisomers: 60-90 % E-form and 10-40 % Z-form | EFSA’ |
(15)
the entry concerning FL No 07.198 is replaced by the following:
| ‘07.198 | Pseudo-ionone | 141-10-6 | 11191 | EFSA’ |
(16)
the entry concerning FL No 07.202 is replaced by the following:
| ‘07.202 | 2,6,6-Trimethylcyclohex-2-en-1-one | 20013-73-4 | EFSA’ |
(17)
the entry concerning FL No 07.204 is replaced by the following:
| ‘07.204 | 3,3,6-Trimethylhepta-1,5-dien-4-one | 546-49-6 | EFSA’ |
(18)
the entry concerning FL No 07.255 is replaced by the following:
| ‘07.255 | l-Piperitone | 4573-50-6 | 1856 | EFSA’ |
(19)
the entry concerning FL No 08.004 is replaced by the following:
| ‘08.004 | Lactic acid | 50-21-5 | 930 | 4 | EFSA’ |
(20)
the entry concerning FL No 09.016 is replaced by the following:
| ‘09.016 | Menthyl acetate | 16409-45-3 | 431 | 206 | JECFA’ |
(21)
the entry concerning FL No 09.131 is replaced by the following:
| ‘09.131 | DL-Isobornyl propionate | 2756-56-1 | 1391 | 412 | EFSA’ |
(22)
the entry concerning FL No 09.132 is replaced by the following:
| ‘09.132 | Benzyl propionate | 122-63-4 | 842 | 413 | EFSA’ |
(23)
the entry concerning FL No 09.266 is replaced by the following:
| ‘09.266 | Hexyl 2-butenoate | 19089-92-0 | 1807 | 10688 | EFSA’ |
(24)
the entry concerning FL No 09.562 is replaced by the following:
| ‘09.562 | trans-3-Hexenyl formate | 56922-80-6 | EFSA’ |
(25)
the entry concerning FL No 09.578 is replaced by the following:
| ‘09.578 | Hexyl (E)-but-2-enoate | 1617-25-0 | 10688 | EFSA’ |
(26)
the entry concerning FL No 09.596 is replaced by the following:
| ‘09.596 | Isopentyl-(Z)-but-2-enoate | 10482-55-0 | EFSA’ |
(27)
the entry concerning FL No 09.854 is replaced by the following:
| ‘09.854 | cis-3-Hexenyl 2-methylbutanoate | 53398-85-9 | EFSA’ |
(28)
the entry concerning FL No 09.858 is replaced by the following:
| ‘09.858 | Phenylmethyl 2-methyl-2-butenoate | 67674-41-3 | Mixture of stereoisomers: 60-90 % E-form and 10-40 % Z-form | EFSA’ |
(29)
the entry concerning FL No 09.880 is replaced by the following:
| ‘09.880 | (Z)-Hept-4-en-2-yl butanoate | 94088-12-7 | EFSA’ |
(30)
the entry concerning FL No 09.936 is replaced by the following:
| ‘09.936 | 4,8-Dimethyl-3,7-nonadien-2-yl acetate | 91418-25-6 | 1847 | EFSA’ |
(31)
the entry concerning FL No 12.075 is replaced by the following:
| ‘12.075 | Methyl prop-1-enyl disulfide | 5905-47-5 | 569 | 11712 | At least 90 %; secondary components 3-4 % dimethyl disulfide and 3-4 % di-1-propenyl disulfide | JECFA’ |
(32)
the entry concerning FL No 12.086 is replaced by the following:
| ‘12.086 | S-Methyl 2-methylbutanethioate | 42075-45-6 | 486 | JECFA’ |
(33)
the entry concerning FL No 12.273 is replaced by the following:
| ‘12.273 | 3-(Methylthio)heptanal | 51755-70-5 | 1692 | At least 92 %; secondary component 5-7 % (E)-hept-2-enal | EFSA’ |
(34)
the entry concerning FL No 13.028 is replaced by the following:
| ‘13.028 | 2-Butyl-5 or 6-keto-1,4-dioxane | 65504-95-2 | 1484 | 2206 | EFSA’ |
(35)
the entry concerning FL No 13.170 is replaced by the following:
| ‘13.170 | 2S-cis-Tetrahydro-4-methyl-2-(2-methyl-1-propenyl)-2H-pyran | 3033-23-6 | EFSA’ |
(36)
the entry concerning FL No 13.190 is replaced by the following:
| ‘13.190 | 3-((2-methyl-3-furyl)thio)-2-butanone | 61295-44-1 | 1525 | EFSA’ |
(37)
the entry concerning FL No 14.067 is replaced by the following:
| ‘14.067 | 2-Ethoxy-3-methylpyrazine | 32737-14-7 | 793 | 11921 | At least 82 % 2-ethoxy-3-methylpyrazine. Secondary components 15 % 2–ethoxy-5-methylpyrazine (CAS no 67845-34-5) or 2-ethoxy-6-methylpyrazine (CAS no 53163-97-6) | EFSA’ |
(38)
the entry concerning FL No 15.134 is replaced by the following:
| ‘15.134 | 2,5-Dihydroxy-1,4-dithiane | 40018-26-6 | 550 | Mixture of diastereoisomers: 25-30 % of (2S,5S and 2R,5R) and 70-75 % (2S,5R and 2R,5S) | EFSA’ |
(39)
the entry concerning FL No 16.095 is replaced by the following:
| ‘16.095 | Cyclopropanecarboxamide, N-[(2E)-3,7-dimethyl-2,6-octadien-1-yl]- | 744251-93-2 | 1779 | EFSA’ |
(40)
the entry concerning FL No 16.123 is replaced by the following:
| ‘16.123 | (1R,2S,5R)-N-(4-Methoxyphenyl)-5-methyl-2-(1-methylethyl)cyclohexanecarboxamide | 68489-09-8 | EFSA’ |
(41)
the entry concerning FL No 17.015 is replaced by the following:
| ‘17.015 | DL-Methylmethioninesulphonium chloride | 3493-12-7 | 1427 | 761 | EFSA’ |
Options/Help
Print Options
PrintThe Whole Regulation
PrintThe Annexes only
Legislation is available in different versions:
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
See additional information alongside the content
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Opening Options
Different options to open legislation in order to view more content on screen at once
More Resources
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as adopted version that was used for the EU Official Journal
- lists of changes made by and/or affecting this legislation item
- all formats of all associated documents
- correction slips
- links to related legislation and further information resources
Timeline of Changes
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
More Resources
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as adopted version that was used for the print copy
- correction slips
Click 'View More' or select 'More Resources' tab for additional information including:
- lists of changes made by and/or affecting this legislation item
- confers power and blanket amendment details
- all formats of all associated documents
- links to related legislation and further information resources
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.